基于文献计量学的中医药治疗老年疾病潜在优势病种研究
作者:
作者单位:

1.天津中医药大学第一附属医院

基金项目:

国家中医药管理局:中医药循证能力提升项目


Research on potential dominant diseases of Traditional Chinese Medicine in the treatment of geriatric diseases based on bibliometrics
Author:
Affiliation:

1.First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,2. National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion

  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [43]
  • | | | |
  • 文章评论
    摘要:

    目的:采用文献计量学方法探究中医药治疗老年疾病的潜在优势病种,以期在临床中更好地发挥中医药治疗的特色和优势。方法:检索近10年在知网、万方、维普、中国生物医学数据库中收录的中医药治疗老年疾病的临床研究文献,统计并分析各疾病的研究变化趋势及临床有效率,以确定中医药治疗的潜在优势病种。结果:检索共获得文献22859篇,最终纳入研究3768篇,根据世界卫生组织关于疾病和有关健康问题的国际统计分类(ICD-11)将疾病归为17类共149个病种,主要以循环系统、骨骼肌肉系统或结缔组织系统、消化系统为主。结论:中医药治疗老年疾病的临床研究涉及病种广泛,但分布不均,最终确定潜在优势病种为骨质疏松、便秘、高血压,潜在次优势病种为心力衰竭、脑卒中、冠心病、糖尿病及其并发症、失眠。

    Abstract:

    Objective In order to effectively use the characteristics and benefits of traditional Chinese medicine in clinical therapy, bibliometric approaches are being used to investigate the Dominant diseases of traditional Chinese medicine in the treatment of Geriatric diseases. Methods The clinical research literature of traditional Chinese medicine in the treatment of Geriatric diseases in the past 10 years was retrieved from CNKI, Wanfang, VIP and CBM. The research trend and clinical efficiency of each disease were statistically analyzed to determine the potential dominant diseases of TCM treatment. Results A total of 22,859 articles were collected, with 3768 being included in the research. According to the International Statistical Classification of Diseases and Related Health Problems (ICD-11) of the World Health Organization, the diseases were classified into 17 categories and 149 diseases, primarily affecting the circulatory system, the skeletal musculoskeletal system or connective tissue system, and the digestive system. Conclusion Traditional Chinese medicine clinical trials on the treatment of geriatric illnesses cover a diverse spectrum of diseases, although the distribution is unequal. Potential dominant illnesses are eventually identified to include osteoporosis, constipation, and hypertension, with heart failure, stroke, coronary heart disease, diabetes and its complications, and insomnia being potential sub-dominant diseases.

    参考文献
    [1] 刘远立, 郑忠伟, 饶克勤. 中国老年健康研究报告(2018)[M]. 北京: 社会科学文献出版社, 2019.
    [2] 王飞. 中医老年病学[M]. 北京: 中国中医药出版社, 2017.
    [3] 王亚军,宋凯.针灸治疗老年病的现状和规律分析[J].辽宁中医杂志,2017,44(11):2388-2390.
    [4] Kim LD, Koncilja K, Nielsen C. Medication management in older adults[J]. Cleve Clin J Med, 2018, 85(2): 129-135.
    [5] 曹洪欣. 中医优势病种临床研究的战略思考与实践[J]. 中医杂志, 2009, 50(01): 11-12.
    [6] 梁子钰,李俊德,龙子弋.中药治疗脾胃病优势病种的文献计量学研究[J].世界中西医结合杂志,2015,10(10):1447-1450+1455.
    [7] 林奕,王学谦,赵晖, 等.中医优势病种评价的方法学探讨[J].中医杂志,2021,62(19):1663-1667.
    [8] Lorentzon M. Treating osteoporosis to prevent fractures: current concepts and future developments[J]. J Intern Med, 2019, 285(4):381-394.
    [9] Chen W, Zhang B, Chang X. Emerging roles of circular RNAs in osteoporosis[J]. J Cell Mol Med, 2021, 25(19):9089-9101.
    [10] S?zen T, ?z???k L, Ba?aran N?. An overview and management of osteoporosis[J]. Eur J Rheumatol, 2017, 4(1):46-56.
    [11] Khosla S, Hofbauer LC. Osteoporosis treatment: recent developments and ongoing challenges[J]. Lancet Diabetes Endocrinol, 2017, 5(11):898-907.
    [12] Liu J, Curtis EM, Cooper C, et al. State of the art in osteoporosis risk assessment and treatment[J]. J Endocrinol Invest, 2019, 42(10):1149-1164.
    [13] Wang Z, Wang D, Yang D, et al. The effect of icariin on bone metabolism and its potential clinical application[J]. Osteoporos Int, 2018, 29(3):535-544.
    [14] 辛红美,许洁,汪长东.淫羊藿苷促进MC3T3-E1成骨分化通过Hedgehog信号通路[J].中国药理学通报,2020,36(05):616-620.
    [15] Tang DZ, Yang F, Yang Z, et al. Psoralen stimulates osteoblast differentiation through activation of BMP signaling[J]. Biochem Biophys Res Commun, 2011, 405(2):256-61.
    [16] 高举会,林庶茹,尚德阳.左归丸对去卵巢致骨质疏松症大鼠Hedgehog/Smo/GLI1表达的影响[J].时珍国医国药,2020,31(03):549-551.
    [17] 高举会,林庶茹,尚德阳.右归丸含药血清对骨髓间充质干细胞Hedgehog信号通路影响[J].辽宁中医药大学学报,2019,21(10):44-46.
    [18] 刘彤,李俊儒,付夜平, 等.“峻补肾阳”之右归丸对骨质疏松症防治的研究进展[J].中国骨质疏松杂志,2022,28(09):1347-1350.
    [19] Shuai B, Zhu R, Yang YP, et al. Positive Effects of Qing''e Pill on Trabecular Microarchitecture and its Mechanical Properties in Osteopenic Ovariectomised Mice[J]. Chin J Integr Med, 2019, 25(4):270-277.
    [20] 白登彦,王冠,张海军, 等.TGF-β1/Smad4信号通路对去卵巢骨质疏松大鼠骨髓微环境的影响及针刺干预机制[J].中国骨质疏松杂志,2021,27(08):1140-1146.
    [21] Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis[J]. Endocr Rev, 2010, 31(3):266-300.
    [22] 王薇,许乐,邱蕾.中国老年人便秘评估技术应用共识(草案)[J].中国老年保健医学,2019,17(04):46-47.
    [23] 中华医学会外科学分会结直肠外科学组. 中国成人慢性便秘评估与外科处理临床实践指南(2022版)[J]. 中华胃肠外科杂志, 2022, 25(1): 1-9.
    [24] 中华医学会老年医学分会. 老年人慢性便秘的评估与处理专家共识[J]. 中华老年医学杂志, 2017, 36(4): 371-381.
    [25] 梁堃.老年便秘的研究进展[J].中国老年学杂志,2006(12):1761-1763.
    [26] 丰胜利.中医治疗老年难治性便秘的现状与思考[J].中医杂志,2020,61(10):905-908.
    [27] azquez Roque M, Bouras EP. Epidemiology and management of chronic constipation in elderly patients[J]. Clin Interv Aging, 2015, 2(10):919-30.
    [28] 夏晨曦,周玲,秦珂馨, 等.基于肠道菌群探讨中医药治疗老年便秘[J].中国老年学杂志,2022,42(01):251-254.
    [29] 《中国心血管健康与疾病报告》编写组. 中国心血管健康与疾病报告2020概要[J].中国循环杂志,2021,36(06):521-545.
    [30] Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: Assessment, management, and challenges[J]. Clin Cardiol, 2020, 43(2):99-107.
    [31] Wang Z, Chen Z, Zhang L, et al. China Hypertension Survey Investigators. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015[J]. Circulation, 2018, 137(22):2344-2356.
    [32] Setters B, Holmes HM. Hypertension in the Older Adult[J]. Prim Care, 2017, 44(3):529-539.
    [33] Oliveros E, Patel H, Kyung S, et al. Hypertension in older adults: Assessment, management, and challenges[J]. Clin Cardiol, 2020, 43(2):99-107.
    [34] 中国老年医学学会高血压分会,北京高血压防治协会,国家老年疾病临床医学研究中心.中国老年高血压管理指南2023[J].中华高血压杂志,2023,31(06):508-538.
    [35] 曹丰,王亚斌,薛万国, 等.中国老年疾病临床多中心报告[J].中华老年多器官疾病杂志,2018,17(11):801-808.
    [36] 中华中医药学会心血管病分会. 高血压中医诊疗专家共识[J].中国实验方剂学杂志,2019,25(15):217-221.
    [37] 薄荣强,胡元会,石晶晶, 等.基于信息计量学关于天麻钩藤饮治疗高血压病随机对照试验的文献研究分析[J].中医药导报,2017,23(24):106-109+133.
    [38] 熊兴江,王阶.论半夏白术天麻汤在高血压病中的运用[J].中华中医药杂志,2012,27(11):2862-2865.
    [39] 刘巍,熊兴江,王阶.论六味地黄丸在高血压病治疗中的运用[J].中华中医药杂志,2013,28(11):3329-3333.
    [40] 田昕彤,周巍,杨继, 等.钩藤及其配伍制剂治疗高血压的研究进展[J].中草药,2023,54(13):4395-4403.
    [41] 范浩浩,董宏利.老年高血压的中医药治疗进展[J].实用老年医学,2023,37(02):119-123.
    [42] Wang J, Xiong X, Liu W. Acupuncture for essential hypertension[J]. Int J Cardiol, 2013, 169(5):317-26.
    [43] 《高血压病治未病干预指南》编写组. 高血压病治未病干预指南[J].北京中医药大学学报,2023,46(08):1063-1075.
    相似文献
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文
分享
文章指标
  • 点击次数:179
  • 下载次数: 0
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2024-03-25
  • 最后修改日期:2024-05-12
  • 录用日期:2024-08-26
防诈骗提示!请勿点击不明链接或添加个人微信。编辑部所有邮箱后缀均为@cnilas.org
关闭